About Us
Founded in 2006, Headway was established to develop and market innovative medical solutions for management and treatment of chronic head and neck pain. The Company operates within the framework of Misgav Venture Accelerator at the Misgav Business Park in Israel. 

Over 10 million people in the U.S. approach their physician every year with a complaint of chronic neck pain. More than 40 million American suffer from chronic recurrent headaches and spend $4 billion every year on medication. Chronic sufferers have few therapeutic options which usually provide temporary relief from pain with an increasing risk of side effects and complications. In addition, current therapy can not be given to pregnant or nursing women or those taking pills to treat other ailments, like heart problems or diabetes.

Based on well-established neurological and physiological principles, Occiflex™, Headway's innovative medical device, relaxes the head and neck muscles, thereby breaking the vicious cycle of pain. Occiflex will meet the needs of the millions of patients who suffer from neck pain (i.e. whiplash, cervical facet-joint disorder and post spinal surgery) and chronic headaches (i.e. tension-type, migraines, cervicogenic, over-use, myofascial, and post-traumatic), who are eager for a highly effective, safe and long term solution with minimal side effects.